The American College of Cardiology (ACC) and OpenEvidence are joining forces in a strategic partnership to revolutionize cardiovascular care. By combining ACC's expertise in cardiovascular science and education with OpenEvidence's cutting-edge generative AI technology, they aim to empower clinicians with the latest, most relevant medical evidence. This collaboration will ensure patients receive timely, evidence-based care without compromising safety or transparency.
The partnership's primary goal is to accelerate the implementation of cardiovascular clinical guidance and research at the point of care. Through this collaboration, OpenEvidence users will gain seamless access to trusted, evidence-based medical content curated by the ACC. The platform's generative AI-powered search capabilities will enhance clinical decision-making with speed and accuracy, catering to various medical professionals, from family physicians to trauma surgeons.
The ACC and OpenEvidence will convene a diverse expert work group comprising cardiovascular clinicians to identify critical areas, frequently asked questions, and knowledge gaps. This group will also explore ways to enhance clinical guidance development and create new educational materials, optimizing the use of generative AI in practice. Additionally, they plan to launch an AI Resource Center and podcast series, shedding light on AI's impact on cardiovascular medicine.
Furthermore, the ACC and OpenEvidence will collaborate on the ACC Future Hub at the ACC Annual Scientific Session. This initiative will provide attendees with hands-on access to groundbreaking technologies that can revolutionize patient care and outcomes. By integrating AI responsibly into clinical workflows, this partnership aims to transform cardiovascular care, ensuring patients receive the best possible treatment informed by the latest scientific evidence.
